{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:36:54Z","timestamp":1791992214110,"version":"4.4.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02337","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T04:30:43Z","timestamp":1570681843000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["The Central Nervous System Contains ILC1s That Differ From NK Cells in the Response to Inflammation"],"prefix":"10.3389","volume":"10","author":[{"given":"Silvina","family":"Romero-Su\u00e1rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Del Rio Serrato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roemel Jeusep","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Brunotte-Strecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Stehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Andreeta","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hertwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildiko R.","family":"Dunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Romagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Infante-Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1126\/science.aac9593","article-title":"Tissue residency of innate lymphoid cells in lymphoid and non-lymphoid organs","volume":"350","author":"Gasteiger","year":"2015","journal-title":"Science."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365.","article-title":"Innate lymphoid cells-a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature13047","article-title":"A committed precursor to innate lymphoid cells","volume":"508","author":"Constantinides","year":"2014","journal-title":"Nature."},{"key":"B5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","article-title":"Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages","volume":"157","author":"Klose","year":"2014","journal-title":"Cell."},{"key":"B6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1084\/jem.20131560","article-title":"T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow","volume":"211","author":"Daussy","year":"2014","journal-title":"J Exp Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.immuni.2011.11.016","article-title":"The transcription factors T-bet and eomes control key checkpoints of natural killer cell maturation","volume":"36","author":"Gordon","year":"2012","journal-title":"Immunity."},{"key":"B8","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1084\/jem.161.6.1315","article-title":"Eradication of established human melanoma tumors in nude mice by antibody-directed effector cells","volume":"161","author":"Schulz","year":"1985","journal-title":"J Exp Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1089\/hyb.1989.8.605","article-title":"Pan natural killer cell monoclonal antibodies and their relationship to the NK1","volume":"8","author":"Sentmann","year":"1989","journal-title":"Hybridoma."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/ni1523","article-title":"Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor","volume":"8","author":"Walzer","year":"2007","journal-title":"Nat Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ni.1681","article-title":"Influence of the transcription factor ROR\u03b3t on the development of NKp46+ cell populations in gut and skin","volume":"10","author":"Luci","year":"2009","journal-title":"Nat Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/ni796","article-title":"In vivo developmental stages in murine natural killer cell maturation","volume":"3","author":"Kim","year":"2002","journal-title":"Nat Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature04606","article-title":"CD69 acts downstream of interferon-\u03b1\/\u03b2 to inhibit S1P1 and lymphocyte egress from lymphoid organs","volume":"440","author":"Shiow","year":"2006","journal-title":"Nature."},{"key":"B14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/372190a0","article-title":"Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the \u03b1E\u03b27 integrin","volume":"372","author":"Cepek","year":"1994","journal-title":"Nature."},{"key":"B15","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1016\/S0021-9258(18)83797-8","article-title":"Identification of integrin collagen receptors on human melanoma cells","volume":"264","author":"Kramer","year":"1989","journal-title":"J Biol Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1096\/fj.05-3832fje","article-title":"Frequency of blood CX3CR1","volume":"19","author":"Infante-Duarte","year":"2005","journal-title":"FASEB J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56 bright natural killer cells mediate immunomodulatory effects of IL-2Ra-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e39625","DOI":"10.1371\/journal.pone.0039625","article-title":"Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis","volume":"7","author":"Chanvillard","year":"2012","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"E2973","DOI":"10.1073\/pnas.1524924113","article-title":"Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation","volume":"113","author":"Gross","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.4049\/JIMMUNOL.180.7.4495","article-title":"In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: alteration of primary adaptive responses","volume":"180","author":"Winkler-Pickett","year":"2008","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nn.4211","article-title":"Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation","volume":"19","author":"Liu","year":"2016","journal-title":"Nat Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1084\/jem.186.10.1677","article-title":"Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells","volume":"186","author":"Zhang","year":"1997","journal-title":"J Exp Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jneuroim.2005.02.011","article-title":"Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis","volume":"163","author":"Xu","year":"2005","journal-title":"J Neuroimmunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1084\/jem.20092749","article-title":"Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology","volume":"207","author":"Hao","year":"2010","journal-title":"J Exp Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/eji.201546194","article-title":"CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation","volume":"46","author":"Hertwig","year":"2016","journal-title":"Eur J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ni.3800","article-title":"Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells","volume":"18","author":"Gao","year":"2017","journal-title":"Nat Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.4049\/jimmunol.1303469","article-title":"Cutting edge: Salivary gland NK cells develop independently of Nfil3 in steady-state","volume":"192","author":"Cortez","year":"2014","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","article-title":"ILC1 confer early host protection at initial sites of viral infection","volume":"171","author":"Weizman","year":"2017","journal-title":"Cell."},{"key":"B29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fimmu.2019.00196","article-title":"Innate lymphoid cells in protection, pathology, and adaptive immunity during apicomplexan infection","volume":"10","author":"Ivanova","year":"2019","journal-title":"Front Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/ni.3816","article-title":"T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of T H 17-induced neuroinflammation","volume":"18","author":"Kwong","year":"2017","journal-title":"Nat Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.4049\/jimmunol.1502396","article-title":"Cutting edge: eomesodermin is sufficient to direct type 1 innate lymphocyte development into the conventional NK lineage","volume":"196","author":"Pikovskaya","year":"2016","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/eji.201747299","article-title":"T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1","volume":"48","author":"Zhang","year":"2018","journal-title":"Eur J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/nn.4610","article-title":"High-dimensional, single-cell characterization of the brain's immune compartment","volume":"20","author":"Korin","year":"2017","journal-title":"Nat Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ni.3094","article-title":"Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets","volume":"1","author":"Robinette","year":"2015","journal-title":"Nat Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1038\/s41467-018-06918-3","article-title":"Molecular definition of group 1 innate lymphoid cells in the mouse uterus","volume":"9","author":"Filipovic","year":"2018","journal-title":"Nat Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1084\/jem.20162031","article-title":"Tissue microenvironment dictates the fate and tumor-suppressive function of type 3 ILCs","volume":"214","author":"Nussbaum","year":"2017","journal-title":"J Exp Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.immuni.2010.10.017","article-title":"Regulated expression of nuclear receptor ROR\u03b3t confers distinct functional fates to NK cell receptor-expressing ROR\u03b3t+ innate lymphocytes","volume":"33","author":"Vonarbourg","year":"2010","journal-title":"Immunity."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.01659","article-title":"Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells","volume":"2014","author":"Sojka","year":"2014","journal-title":"eLife."},{"key":"B39","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/J.IMMUNI.2013.02.010","article-title":"Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-\u03b3-producing cells","volume":"38","author":"Fuchs","year":"2013","journal-title":"Immunity."},{"key":"B40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fncel.2017.00129","article-title":"Alterations in CD200-CD200R1 system during EAE already manifest at presymptomatic stages","volume":"11","author":"Valente","year":"2017","journal-title":"Front Cell Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/J.JNEUROIM.2007.11.013","article-title":"CNS inflammation and neuronal degeneration is aggravated by impaired CD200\u2013CD200R-mediated macrophage silencing","volume":"194","author":"Meuth","year":"2008","journal-title":"J Neuroimmunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1523\/JNEUROSCI.4272-09.2010","article-title":"CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis","volume":"30","author":"Liu","year":"2010","journal-title":"J Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.4049\/jimmunol.180.10.6713","article-title":"The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor","volume":"180","author":"Meiser","year":"2008","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/glia.20587","article-title":"Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-\u03b3 but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro","volume":"55","author":"Carter","year":"2007","journal-title":"Glia."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/labinvest.3700155","article-title":"Expression of rat I-TAC\/CXCL11\/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands","volume":"84","author":"McColl","year":"2004","journal-title":"Lab Invest."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/j.1471-4159.2005.03123.x","article-title":"Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells","volume":"93","author":"Ludwig","year":"2005","journal-title":"J Neurochem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1523\/JNEUROSCI.4046-11.2012","article-title":"CXCL16 orchestrates adenosine A3 receptor and MCP-1\/CCL2 activity to protect neurons from excitotoxic cell death in the CNS","volume":"32","author":"Rosito","year":"2012","journal-title":"J Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neulet.2005.12.029","article-title":"CXCL16 is elevated in the cerebrospinal fluid versus serum and in inflammatory conditions with suspected and proved central nervous system involvement","volume":"397","author":"le Blanc","year":"2006","journal-title":"Neurosci Lett."},{"key":"B49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fncel.2014.00193","article-title":"Trasmembrane chemokines CX3CL1 and CXCL16 drive interplay between neurons, microglia and astrocytes to counteract pMCAO and excitotoxic neuronal death","volume":"8","author":"Rosito","year":"2014","journal-title":"Front Cell Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/ni.1953","article-title":"Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses","volume":"11","author":"Paust","year":"2010","journal-title":"Nat Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4049\/jimmunol.1701124","article-title":"Tissue-resident cytolytic innate lymphocytes in cancer","volume":"200","author":"Nixon","year":"2018","journal-title":"J Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1182\/blood-2004-08-3262","article-title":"TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver","volume":"105","author":"Takeda","year":"2005","journal-title":"Blood."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1182\/blood-2003-08-2806","article-title":"IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL\/Apo-2 ligand) displaying apoptotic activity on leukemic cells","volume":"103","author":"Tecchio","year":"2004","journal-title":"Blood."},{"key":"B54","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T","article-title":"Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage","volume":"28","author":"Mariani","year":"1998","journal-title":"Eur J Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"14475","DOI":"10.3390\/ijms140714475","article-title":"Membrane trafficking of death receptors: implications on signalling","volume":"14","author":"Schneider-Brachert","year":"2013","journal-title":"Int J Mol Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/archneur.64.2.185","article-title":"Neuronal damage in brain inflammation","volume":"64","author":"Aktas","year":"2007","journal-title":"JAMA."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.4049\/jimmunol.166.2.1314","article-title":"Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis","volume":"166","author":"Hilliard","year":"2001","journal-title":"J Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.4049\/jimmunol.0902797","article-title":"Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells","volume":"185","author":"Ikeda","year":"2010","journal-title":"J Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e31959","DOI":"10.1371\/journal.pone.0031959","article-title":"Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94\/NKG2A","volume":"7","author":"Nielsen","year":"2012","journal-title":"PLoS ONE."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e12516","DOI":"10.1111\/pim.12516","article-title":"Group 1 innate lymphoid cells in Toxoplasma gondii infection","volume":"40","author":"Dunay","year":"2018","journal-title":"Parasite Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/eji.201343653","article-title":"Thy1+ Sca1+ innate lymphoid cells infiltrate the CNS during autoimmune inflammation, but do not contribute to disease development","volume":"44","author":"Mair","year":"2014","journal-title":"Eur J Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/J.CELLIMM.2015.06.006","article-title":"Group 3 innate lymphoid cells accumulate and exhibit disease-induced activation in the meninges in EAE","volume":"297","author":"Hatfield","year":"2015","journal-title":"Cell Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"AN20120081","DOI":"10.1042\/AN20120081","article-title":"Iron oxide magnetic nanoparticles highlight early involvement of the choroid plexus in central nervous system inflammation","volume":"5","author":"Millward","year":"2013","journal-title":"ASN Neuro."},{"key":"B64","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.it.2016.01.006","article-title":"Type I\/II interferon balance in the regulation of brain physiology and pathology","volume":"37","author":"Deczkowska","year":"2016","journal-title":"Trends Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/brain\/awt259","article-title":"IFN-\u03b3-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair","volume":"136","author":"Kunis","year":"2013","journal-title":"Brain."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1073\/pnas.1211270110","article-title":"CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging","volume":"110","author":"Baruch","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B67","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1128\/JVI.78.2.585-594.2004","article-title":"CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells","volume":"78","author":"Trifilo","year":"2004","journal-title":"J Virol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1096\/fj.05-5465com","article-title":"The neuronal chemokine CX3CL1\/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system","volume":"20","author":"Huang","year":"2006","journal-title":"FASEB J."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02337\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T12:06:30Z","timestamp":1611489990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02337\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":68,"alternative-id":["10.3389\/fimmu.2019.02337"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02337","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"article-number":"2337"}}